FDA issues alert on potential dangers of unproven treatment for multiple sclerosis
date:May 11, 2012
n and spinal cord. In MS, the lining around nerve fibers, and often the nerve fibers themselves, in the brain and spinal cord are injured, resulting in significant and disabling neurological symptoms. The underlying cause of MS is not known.


Complications following CCSVI treatment can be reported through MedWatch, the FDA Safety Information and Adverse Event Reporting program.


The FDA also is notifying physicians and clinical investigators who are planning or conducting clinical trials using
4/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/04 00:58